CAD-CAM TECHNOLOGY FOR DIABETIC FOOTWEAR

描述（申请人摘要）：超过15%的糖尿病患者 (DM)会出现足部溃疡这类病人必须穿特殊的鞋 终身使用以防止复发。目前，设计和制造 治疗鞋主要基于主观标准。成功 鞋子通常由经验丰富的工匠制作， 经常需要。在研究的两个阶段，我们将制定一个完整的 治疗鞋系统的风险糖尿病患者，将纳入：数据 采集;鞋垫自动算法; CAD-CAM制造系统; 以及用于包括外底修改的鞋选择的系统。初步 研究为鞋内环境的分析提供了经验和技术 足底压力分布，市场研究表明， 需要为这个问题提供一种全面的鞋类解决方案。 拟议的商业应用：两种可能相互竞争的CAD-CAM产品 帮助医生为糖尿病患者设计定制鞋 患者两者都很昂贵，而DIApedia LLC将其系统推向市场， 只有五千到一万美元潜在的美国和欧洲市场是 每个估计超过2500万美元：日本市场将是 大约是这个数量的一半。全球市场潜力预计为 超过六千五百万美元该公司将有一个持续的收入来源， 一双鞋子是生产出来的。

DESCRIPTION (Applicant's Abstract): Over 15 percent of diabetic patients (DM) will experience a foot ulcer. Such patients must use special footwear for life to prevent recurrence. Currently the design and manufacture of therapeutic footwear is largely based on subjective criteria. Successful shoes are usually made by experienced craftspeople and many iterations are often required. We will, over both phases of the study, develop an entire therapeutic shoe system for at risk DM patients that will incorporate: data collection; automatic algorithm for insoles; CAD-CAM system for manufacture; and system for shoe selection including outsole modifications. Preliminary studies have provided experience and techniques for the analysis of in-shoe plantar pressure distribution, and market research has indicated that there is a need to provide a comprehensive footwear solution for this problem. PROPOSED COMMERCIAL APPLICATION: Two potentially competing CAD-CAM products are on the market to help physicians design custom footware for diabetic patients. Both are expensive, while DIApedia LLC will market its system for only between $5,000 and $10,000. The potential U.S. and European markets are each estimated to be more than $25 million: the Japanese market would be about half of this amount. The worldwide market potential is estimated to be over $65 million. The company will have an ongoing revenue stream from each pair of shoes that is produced.